MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
0.5299
-0.0582
-9.90%
Opening 12:12 03/27 EDT
OPEN
0.5540
PREV CLOSE
0.5881
HIGH
0.5706
LOW
0.4111
VOLUME
21.97K
TURNOVER
--
52 WEEK HIGH
2.680
52 WEEK LOW
0.4111
MARKET CAP
3.49M
P/E (TTM)
-0.1474
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLMD last week (0316-0320)?
Weekly Report · 4d ago
Galmed Pharmaceuticals Ltd. CSO Liat Nissimov Brueck filed Form 3 initial beneficial ownership statement
Reuters · 03/18 11:46
Galmed Pharmaceuticals Ltd. CFO Doron Leib Cohen files initial beneficial ownership statement
Reuters · 03/18 11:46
Galmed Pharmaceuticals names Chief Accounting Officer Yohai Stenzler in initial beneficial ownership filing
Reuters · 03/18 11:46
Galmed Pharmaceuticals names CEO Allen Baharaff in initial beneficial ownership filing
Reuters · 03/18 11:46
Weekly Report: what happened at GLMD last week (0309-0313)?
Weekly Report · 03/16 09:13
Weekly Report: what happened at GLMD last week (0302-0306)?
Weekly Report · 03/09 09:13
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting
TipRanks · 03/05 21:27
More
About GLMD
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.